← board
RVRC
distress 6/10 · elevated risk$1.670%today0% from 52w high
Revenue
pre-revenue
Liquidity
$1M
Runway
0.4 yrs
Shares 1y
-1%
Price & events
+11.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
+0.0%
1M
+0.0%
3M
+11.3%
6M
+234.0%
1Y
+11.3%
2Y
+32.5%
5Y
+40.3%
All
Overview
- Market Cap
- $101.42M
- Volume
- 0
- 52 Week Range
- $0.50 – $1.67
- Total Shares
- 60.73M
- Float Shares
- 21.92M
- % Held by Insiders
- 56.70%
- % Held by Institutions
- 0.00%
- Beta
- -0.78
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.